Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
FGFR阻害剤の固体形態及びその調製プロセス
Document Type and Number:
Japanese Patent JP2021523121
Kind Code:
A
Abstract:
本開示は、がんなどのFGFR関連疾患または媒介疾患の治療に有用である、3−(2,6−ジフルオロ−3,5−ジメトキシフェニル)−1−エチル−8−(モルホリン−4−イル−メチル)−1,3,4,7−テトラヒドロ−2H−ピロロ[3’,2’:5,6]ピリド[4,3−d]ピリミジン−2−オン、その固体形態及び多形体、その調製方法、及びその調製における中間体に関する。

Inventors:
Timothy Sea Burn
Philip Sea Liu
William Fryce
John Gian Zia
Min Tao
Denjin One
Jiachen Chow
Lee Chun
Application Number:
JP2020561741A
Publication Date:
September 02, 2021
Filing Date:
May 03, 2019
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
INCYTE CORPORATION
International Classes:
C07D471/14; A61K9/20; A61K31/5377; A61P35/00; A61P35/04
Domestic Patent References:
JP2015521600A2015-07-30
JP2009536959A2009-10-22
Other References:
PHARM TECH JAPAN, vol. 18, no. 10, JPN7014002019, 2002, pages 81 - 96, ISSN: 0005016967
CAIRA, MINO R.: "Crystalline Polymorphism of Organic Compounds", TOPICS IN CURRENT CHEMISTRY, vol. 198, JPN7023001155, 1998, pages 163 - 208, XP008166276, ISSN: 0005016968, DOI: 10.1007/3-540-69178-2_5
HEINRICH, T. ET AL.: "Fragment-Based Discovery of New Highly Substituted 1H-Pyrrolo[2,3-b]- and 3H-Imidazolo[4,5-b]-Pyridi", JOURNAL OF MEDICINAL CHEMISTRY, vol. 56(3), JPN6023011502, 2013, pages 1160 - 1170, ISSN: 0005016969
Attorney, Agent or Firm:
Michiko Matsutani
Yasushi Ochiai